高级检索
洪艳, 阮冰, 杨连华, 经络, 王怡婷, 陈勇. 戊型肝炎病毒嵌合基因疫苗的初步研究[J]. 中国公共卫生, 2004, 20(7): 887-888.
引用本文: 洪艳, 阮冰, 杨连华, 经络, 王怡婷, 陈勇. 戊型肝炎病毒嵌合基因疫苗的初步研究[J]. 中国公共卫生, 2004, 20(7): 887-888.
HONG Yan, RUAN Bing, YANG Lian-hua, . Preliminary research on hepatitis E virus chimeric DNA vaccine[J]. Chinese Journal of Public Health, 2004, 20(7): 887-888.
Citation: HONG Yan, RUAN Bing, YANG Lian-hua, . Preliminary research on hepatitis E virus chimeric DNA vaccine[J]. Chinese Journal of Public Health, 2004, 20(7): 887-888.

戊型肝炎病毒嵌合基因疫苗的初步研究

Preliminary research on hepatitis E virus chimeric DNA vaccine

  • 摘要:
      目的   构建含戊型肝炎病毒(HEV)开放读码框架(ORF2)和ORF3嵌合基因的重组质粒, 并探讨其作为DNA疫苗的可能性。
      方法   利用PCR方法获得约0.8kb的戊型肝炎ORF2片段和ORF3的完整片段, 同时将2段片段克隆到同一真核表达载体pcDNA3中, 构建出含有ORF2和ORF3嵌合基因的质粒pcHEV23;该重组质粒作为DNA疫苗免疫BALB/c小鼠, 观察其在小鼠体内诱发的体液免疫应答和细胞免疫应答。
      结果   质粒DpcHEV23免疫组小鼠特异性抗体水平明显高于对照组。T细胞增殖反应显著强于空质粒对照组(P < 0.05), 与生理盐水对照组比较有显著性差异(P < 0.01)。
      结论   重组质粒pcHEV23可诱发小鼠产生特异性体液和细胞免疫应答, 可为戊型肝炎DNA疫苗的研制提供依据。

     

    Abstract:
      Objective   To construct a recombinant plasmid which contained fragments of HEVORF2 and ORF3 chimeric gene, and then assess its feasibility for use as a DNA vaccine.
      Methods   HEVORF2 fragment and full-length ORF2 was amplified by PCR.The PCR products were inserted into an eucaryotic expression plasmid pcDNA 3 to form a recombinant plasmid named pcHEV23(DNA vaccine).BALB/c mice were immunized with DNA vaccine and the humoral and cellular immune responses of the mice were detected.
      Results   The HEVDNA vaccine can induce specific anti-HEV IgG and T lymphocyte proliferation. The lymphocyte stimulation index(SI)in the group immunized with pcHEV23 was high than that in control group(P < 0.01).
      Conclusion   HEV DNA vaccine constructed by us can successfully induce both humoral and cellular immune response. Thus providing an experimental evidence for its use in control of HEV infection.

     

/

返回文章
返回